Health & Biotech
ASX Health Stocks: Microba is set to enter preclinical assessment as early as this year
Wellnex set to launch direct-to-consumer platform to escape inflation pressure cooker & boost margins
EZZ to launch store on Chinese version of TikTok
Bone specialist Osteopore finishes solid quarter, set for new technologies and markets
Nanollose finishes milestone March quarter well-positioned for next growth stage
Reaching new heights: Milestone Q1 sets Nutritional Growth Solutions up for future growth
Cannabis play Cronos delivers record quarter with $18m in cash receipts, sets up for long-term market leadership
Osteopore’s star CTO gets added operations role to accelerate next-gen bone regeneration technology
ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis
With $40m in the bank and an exciting product suite, Incannex targets game-changing US acquisition for even more growth
Dimerix hits more key milestones in Q3, as major global trials across its core product suite continue to advance
Who’s carrying on the Cochlear legacy? The ASX med device stocks that could soar from tailwinds
Check Up: Money managers are still bullish on Healthcare; here’s what they said
Twin contracts a validation of Opyl’s pivot to AI and the success of its flagship platform, Opin
EZZ posts ~$4 million cash inflows in Q3 as Covid-19 recovery continues
Why millions of Aussie patients could be lining up for over-the-counter CBD… but not until 2023
Growing Goliaths: NGS scientifically-backed products to unlock kids’ highest potential
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
